TPP raises £9.6 million for early drug development in Scotland
This article was originally published in Scrip
Executive Summary
In a move that will boost Scotland's growing reputation as a base for life sciences research, the UK-based drug development company, TPP Global Development, has decided to set up its new headquarters in the Edinburgh BioQuarter. It has also raised £9.6 million for use in developing early-stage preclinical drug candidates.